Table 1. Baseline characteristics.
| Characteristic | Antenatal MG ( n = 95) | Control ( n = 10) | p -Value |
|---|---|---|---|
| Birth weight (g) | 1007 ± 271 | 1,030 ± 329 | 0.81 |
| Sex (male) n (%) | 48 (51) | 5 (50) | 0.61 |
| Gestational age (wk) | 27.8 ± 2.3 | 27.6 ± 2.5 | 0.79 |
| Race n (%) | |||
| Hispanic | 36 (38) | 6 (60) | 0.11 |
| Caucasian | 29 (30.5) | 3 (30) | |
| African American | 29 (30.5) | 1 (10) | |
| Asian | 1 (1) | 0 (0) | |
| Antenatal steroid use | 74 (78) | 5 (50) | 0.12 |
| BPD n (%) | 24 (25) | 3 (30) | 0.7 |
| NEC n (%) | 9 (9.5) | 1 (10) | 1.0 |
| IVH n (%) | 7 (7.4) | 2 (20) | 0.2 |
| HsPDA n (%) | 12 (13) | 4 (40) | 0.04 |
| PDA treatment n (%) | 15 (16) | 4 (40) | 0.08 |
Abbreviations: BPD, bronchopulmonary dysplasia; HsPDA, hemodynamically significant patent ductus arteriosus; IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitis; MG, Magnesium sulfate.